Use of hif alpha stabilizers for enhancing erythropoiesis

摘要

The invention relates to the methods for treatment or prevention of anemia caused by chronic disease, iron deficiency, microcytosis or microcytic anemia, anemia, connected with cytokine activity, anemia, which is difficult to treat by erythropoietin (ЕРО), which is administered exogenously using efficient amount ofHIF prolylhydroxylase inhibitor, which represents the structural mimetic of 2-oxoglutarate.